Hunt Anthony
SEC CIK 1606030 · EDGAR
BoughtSold
Most active insiders at MASS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | AWM Investment Company, Inc. | 10% | — | $3.68M |
| 2 | Knopp Kevin J. | Pres, CEO, Dir | — | $2.55M |
| 3 | Brown Christopher D. | Dir | — | $1.81M |
| 4 | Kenneweg John | SVP, Sales, Product Marketing | — | $481.3K |
| 5 | Griffith Joseph H. IV | CFO | — | $376.6K |
| 6 | McCallion Kevin J. | SVP, Products, Production | — | $188.1K |
| 7 | Vann Brandi C | Dir | — | — |
| 8 | Leonhart Michele M. | Dir | — | — |
| 9 | Spoto Mark | Dir | — | — |
| 10 | Hunt Anthony | Dir | — | — |
Transactions 60
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-12 16:48 | 2026-06-10 | MASS | 908 Devices Inc. | Hunt Anthony | Dir | M - OptEx | — | +14.1K | 44.2K | +47% | — |
| 2026-03-03 | 2026-03-02 | RGEN | REPLIGEN CORP | Hunt Anthony | Dir | F - Tax | $124.97 | -9,897 | 89.1K | -10% | -$1.24M | |
| 2026-02-26 | 2026-02-24 | BLFS | BIOLIFE SOLUTIONS INC | Hunt Anthony | Dir | A - Grant | — | +8,170 | 15.0K | +119% | — | |
| 2025-12-08 | 2025-12-04 | RGEN | REPLIGEN CORP | Hunt Anthony | Dir | J - Other | — | -2,000 | 99.0K | -2% | — | |
| DM | 2025-11-14 | 2025-11-13 | RGEN | REPLIGEN CORP | Hunt Anthony | Dir | S - Sale+OE | $154.61 | -20.0K | 80.7K | -20% | -$3.09M |
| D | 2025-11-14 | 2025-11-13 | RGEN | REPLIGEN CORP | Hunt Anthony | Dir | M - OptEx | $33.87 | +2,952 | 83.7K | +4% | +$100.0K |
| DT | 2025-11-13 | 2025-11-12 | RGEN | REPLIGEN CORP | Hunt Anthony | Dir | M - OptEx | $33.87 | +25.0K | 125.7K | +25% | +$846.7K |
| DMT | 2025-11-13 | 2025-11-12 | RGEN | REPLIGEN CORP | Hunt Anthony | Dir | S - Sale+OE | $156.88 | -25.0K | 101.2K | -20% | -$3.92M |
| DM | 2025-09-11 | 2025-09-10 | RGEN | REPLIGEN CORP | Hunt Anthony | Dir | S - Sale+OE | $120.52 | -29.1K | 102.9K | -22% | -$3.51M |
| D | 2025-09-11 | 2025-09-10 | RGEN | REPLIGEN CORP | Hunt Anthony | Dir | M - OptEx | $33.87 | +20.0K | 129.9K | +18% | +$677.4K |
| D | 2025-06-13 | 2025-06-11 | MASS | 908 Devices Inc. | Hunt Anthony | Dir | M - OptEx | — | +11.4K | 30.1K | +61% | — |
| MT | 2025-05-16 | 2025-05-15 | RGEN | REPLIGEN CORP | Hunt Anthony | Dir | S - Sale | $123.71 | -26.4K | 110.1K | -19% | -$3.27M |
| 2025-03-20 | 2025-03-18 | BLFS | BIOLIFE SOLUTIONS INC | Hunt Anthony | Dir | A - Grant | — | +6,876 | 6,876 | New | — | |
| DMT | 2025-03-19 | 2025-03-17 | RGEN | REPLIGEN CORP | Hunt Anthony | Dir | S - Sale+OE | $152.51 | -26.8K | 163.0K | -14% | -$4.08M |
| DMT | 2025-03-19 | 2025-03-17 | RGEN | REPLIGEN CORP | Hunt Anthony | Dir | M - OptEx | $54.73 | +26.8K | 163.1K | +20% | +$1.46M |
| 2025-03-04 | 2025-03-03 | RGEN | REPLIGEN CORP | Hunt Anthony | Dir | F - Tax | $155.38 | -10.1K | 136.3K | -7% | -$1.58M | |
| D | 2025-03-04 | 2025-03-02 | MASS | 908 Devices Inc. | Hunt Anthony | Dir | M - OptEx | — | +2,058 | 18.7K | +12% | — |
| 2025-02-28 | 2025-02-27 | RGEN | REPLIGEN CORP | Hunt Anthony | Dir | F - Tax | $156.54 | -2,825 | 146.4K | -2% | -$442.2K | |
| 2025-02-25 | 2025-02-24 | RGEN | REPLIGEN CORP | Hunt Anthony | Dir | F - Tax | $164.74 | -2,380 | 149.3K | -2% | -$392.1K | |
| D | 2024-12-05 | 2024-12-05 | RGEN | REPLIGEN CORP | Hunt Anthony | Dir | M - OptEx | $33.87 | +11.8K | 151.6K | +8% | +$399.9K |
| D | 2024-11-22 | 2024-11-21 | RGEN | REPLIGEN CORP | Hunt Anthony | Dir | S - Sale+OE | $139.67 | -24.2K | 139.8K | -15% | -$3.39M |
| D | 2024-11-22 | 2024-11-21 | RGEN | REPLIGEN CORP | Hunt Anthony | Dir | M - OptEx | $33.87 | +24.2K | 164.1K | +17% | +$821.2K |
| DMT | 2024-09-12 | 2024-09-10 | RGEN | REPLIGEN CORP | Hunt Anthony | Dir | S - Sale+OE | $145.37 | -22.2K | 160.5K | -12% | -$3.23M |
| DT | 2024-09-12 | 2024-09-10 | RGEN | REPLIGEN CORP | Hunt Anthony | Dir | M - OptEx | $33.87 | +10.0K | 162.0K | +7% | +$338.7K |
| D | 2024-09-04 | 2024-09-03 | RGEN | REPLIGEN CORP | Hunt Anthony | Dir | D - Sale to Iss | $0.00 | -13.1K | 152.0K | -8% | $0 |
| 2024-06-14 | 2024-06-14 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO | P - Purchase | $124.08 | +2,000 | 165.2K | +1% | +$248.2K | |
| D | 2024-06-14 | 2024-06-12 | MASS | 908 Devices Inc. | Hunt Anthony | Dir | M - OptEx | — | +7,777 | 16.7K | +88% | — |
| MT | 2024-05-22 | 2024-05-21 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO | S - Sale | $168.26 | -20.1K | 168.1K | -11% | -$3.38M |
| 2024-03-20 | 2024-03-18 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO | G - Gift | $0.00 | -2,000 | 183.2K | -1% | $0 | |
| DMT | 2024-03-11 | 2024-03-08 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO | S - Sale+OE | $197.44 | -16.7K | 192.4K | -8% | -$3.30M |
| DT | 2024-03-11 | 2024-03-08 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO | M - OptEx | $16.55 | +1 | 202.0K | +0.0% | +$16.55 |
| 2024-03-07 | 2024-03-07 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO | F - Tax | $195.72 | -2,867 | 202.0K | -1% | -$561.1K | |
| M | 2024-03-06 | 2024-03-04+ | RGEN | REPLIGEN CORP | Hunt Anthony | CEO | F - Tax | $195.32 | -8,386 | 212.1K | -4% | -$1.64M |
| D | 2024-03-05 | 2024-03-04 | MASS | 908 Devices Inc. | Hunt Anthony | Dir | M - OptEx | — | +2,057 | 8,886 | +30% | — |
| 2024-03-04 | 2024-03-01 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO | F - Tax | $191.79 | -3,322 | 213.2K | -2% | -$637.1K | |
| 2024-03-04 | 2024-02-29 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO | A - Grant | $0.00 | +2,504 | 216.5K | +1% | $0 | |
| D | 2024-02-29 | 2024-02-27 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO | A - Grant | $0.00 | +19.7K | 214.0K | +10% | $0 |
| 2023-11-16 | 2023-11-14 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO | G - Gift | $0.00 | -1,000 | 194.3K | -0.5% | $0 | |
| D | 2023-06-16 | 2023-06-14 | MASS | 908 Devices Inc. | Hunt Anthony | Dir | M - OptEx | — | +4,771 | 6,829 | +232% | — |
| D | 2023-03-07 | 2023-03-02 | MASS | 908 Devices Inc. | Hunt Anthony | Dir | M - OptEx | — | +2,058 | 2,058 | New | — |
| DM | 2023-03-06 | 2023-03-02+ | RGEN | REPLIGEN CORP | Hunt Anthony | CEO, Dir | A - Grant | $0.00 | +38.0K | 203.6K | +23% | $0 |
| D | 2023-03-06 | 2023-03-03 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO, Dir | F - Tax | $188.00 | -8,244 | 195.3K | -4% | -$1.55M |
| M | 2023-03-02 | 2023-02-28+ | RGEN | REPLIGEN CORP | Hunt Anthony | CEO, Dir | F - Tax | $175.47 | -9,418 | 165.6K | -5% | -$1.65M |
| 2023-02-28 | 2023-02-28 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO, Dir | F - Tax | $173.44 | -3,273 | 175.0K | -2% | -$567.7K | |
| D | 2022-11-14 | 2022-11-11 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO, Dir | M - OptEx | $33.87 | +25.0K | 203.3K | +14% | +$846.7K |
| D | 2022-11-14 | 2022-11-11 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO, Dir | S - Sale+OE | $200.00 | -25.0K | 178.3K | -12% | -$5.00M |
| DM | 2022-09-09 | 2022-09-08 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO, Dir | S - Sale+OE | $224.73 | -26.4K | 203.8K | -11% | -$5.93M |
| D | 2022-09-09 | 2022-09-08 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO, Dir | M - OptEx | $33.87 | +10.0K | 204.7K | +5% | +$338.7K |
| DM | 2022-07-22 | 2022-07-21 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO, Dir | M - OptEx | $32.76 | +20.2K | 219.5K | +10% | +$660.3K |
| D | 2022-07-22 | 2022-07-21 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO, Dir | S - Sale+OE | $200.00 | -24.8K | 194.7K | -11% | -$4.96M |
| 2022-03-03 | 2022-03-01 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO, Dir | F - Tax | $194.06 | -7,292 | 199.3K | -4% | -$1.42M | |
| 2022-03-02 | 2022-02-28 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO, Dir | A - Grant | $0.00 | +30.1K | 220.0K | +16% | $0 | |
| M | 2022-03-02 | 2022-02-27+ | RGEN | REPLIGEN CORP | Hunt Anthony | CEO, Dir | F - Tax | $196.70 | -19.3K | 193.1K | -9% | -$3.79M |
| D | 2022-02-28 | 2022-02-24 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO, Dir | F - Tax | $189.21 | -1,170 | 195.8K | -0.6% | -$221.4K |
| D | 2022-02-28 | 2022-02-24 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO, Dir | A - Grant | $0.00 | +15.9K | 197.0K | +9% | $0 |
| DM | 2021-11-19 | 2021-11-18 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO, Dir | S - Sale+OE | $276.85 | -17.4K | 183.7K | -9% | -$4.80M |
| D | 2021-11-19 | 2021-11-18 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO, Dir | M - OptEx | $32.40 | -10.0K | 199.5K | -5% | -$324.0K |
| DM | 2021-09-13 | 2021-09-09 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO, Dir | S - Sale+OE | $294.75 | -25.0K | 189.5K | -12% | -$7.37M |
| D | 2021-09-13 | 2021-09-09 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO, Dir | M - OptEx | $32.40 | +25.0K | 214.5K | +13% | +$810.0K |
| 2021-08-18 | 2021-08-17 | RGEN | REPLIGEN CORP | Hunt Anthony | CEO, Dir | G - Gift | $0.00 | -1,000 | 189.5K | -0.5% | $0 |
Purchase Sale Sale after option exercise All abbreviations